Case File
efta-02411977DOJ Data Set 11OtherEFTA02411977
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02411977
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey [email protected]]
From:
David Stem
Sent
Wed 6/23/2010 1:50:48 PM
Subject Re:
Understood and confirmed: it will be done as Asia Gateway.
PA agrees to your decision.
Letter will be send as below:
Your Royal Highness,
I would like to take this opportunity to inform you about the Asia Gateway Group ("AG"), an
advisory firm based in South Kensington, London.
AG focuses on developing, structuring and investing in a wide range of projects, specifically
connected to the United Kingdom.
My deep admiration for your relentless work as the UK's Special Representative for International
Trade and Investment serves as inspiration to the AG business model. Knowing your
commitment to the UK and its trade and businesses I wonder if there is not more that could be
done to establish a business network of unrivalled comparison.
Additionally and based on my thirteen years of business experience with China, AG aims to attract
Chinese investors and companies to the UK market and relevant opportunities. I know this is an
area of opportunity for the UK as a whole and is a priority for the UK government.
I would be most honoured to discuss this approach with you personally and to understand, if it
were possible, how AG can support your crucial work.
Yours sincerely,
On 23 Jun 2010, at 13:32, Jeffrey Epstein wrote:
Send asia gateway
On Wed, Jun 23, 2010 at 8:31 AM, David Stem ‹
> wrote:
Informed PA that you are thinking about the company set up and I will wait for
your feedback before taking action.
He replied, saying that I should at least send the letter so we can proceed....
I will wait for your instructions.
Options
- Serpentine Group would be new company for this purpose only (at present I would be
sole director and sole shareholder)
EFTA_R1_01473508
EFTA02411977
- Asia Gateway has history and accounts and prove of clients in the past and can be used (i
am sole director and sole shareholder)
- or ??
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jcevacationesmail.com, and
destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_01473509
EFTA02411978
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.